Clinical trials are costly necessities for research and development (R&D) of novel devices and treatments, yet with more than half failing to finish, they become even costlier for pharmaceutical companies. Without R&D, we would not have products like birth control or cancer interventions. To protect organizations financially that build the cures of the future, we… Continue reading The Hidden Costs and Consequences of Delaying a Clinical Trial
How can Biotechnology and Medtech device companies use AI to increase Diversity in their clinical trials? Global pharmaceutical companies will need to make use of AI’s transformative potential in addressing the diversity gap in clinical trials to illuminate a pathway towards more inclusive, accessible and patient-centric healthcare practices. Innovative biotechnology and Medtech device companies are… Continue reading Pharma to use AI to increase Diversity in their clinical trials
Workflow optimisation is about using strategies and tactics to improve the efficiency of administrative and other processes in clinical trials. A successful workflow optimisation will reduce costs, decrease the incidence of errors and time spent completing clinical trials. This blog explains the significance of using Workflow optimisation strategies in the clinical trial progress by reflecting… Continue reading Workflow Optimisation is Crucial for Clinical Trial Progress
The new Clinical Trial Regulation (CTR) is set to revolutionize clinical trial processes throughout Europe, affecting all European Union (EU) member states and organizations headquartered in other countries wishing to conduct clinical trials on Investigational Medicinal Products (IMPs) in the area. Clinical Trials Information System (CTIS), a centralized portal/application, will be used to standardize… Continue reading Clinical Trial Regulation (CTR) Will Transform Clinical Trial Processes
Capabilities of AI-Enabled Platforms Clinical trials may be revolutionized via the implementation of AI-enabled digital health technologies and patient support platforms such as Clinials, resulting in greater success in attracting, engaging, and retaining engaged participants throughout the study’s course. With artificial intelligence, clinical trial cycle duration can be shortened, while productivity and results in clinical… Continue reading Capabilities of AI-Enabled Platforms
Upcoming Layperson/Plain Language Summary (PLS) Regulations The much-anticipated 2014 European Union Clinical Trial Regulation 536 (EU CTR) requiring the sponsors and academic researchers conducting research trials to draft layperson/plain language summaries (PLS) is set to go into effect in 2023. The regulation will most likely flow to other countries and will be adopted by various… Continue reading Upcoming Layperson/Plain Language Summary (PLS) Regulations
Parallelization is a Good Approach in Clinical Trials The pandemic has forced the industry to develop and implement new methods of working, trial design, and data management. According to a recent Oracle and Informa survey, 63% of organizations have implemented some kind of protocol reform as they transition to a more decentralized trial model. Hence,… Continue reading Parallelization is a Good Approach in Clinical Trials
Managing Research and Clinical Trials Through COVID-19 Disruptions Living through the COVID-19 pandemic has taught us all — especially in the medical industry — many things about resilience, preparedness, and deliberation. The way the coronavirus moves and grows has proven to be erratic and unpredictable, and the public, private, and governmental sectors have all had… Continue reading Managing Research and Clinical Trials Through COVID-19 Disruptions
Where Are Clinical Trials Headed in 2022? It’s been a big two years for the medical industry. Hospitals have been inundated, frontline staff have worked tirelessly to keep the public safe, and researchers have poured their blood sweat and tears into developing vaccines to contain the COVID-19 spread. We’re staring down the barrel of it… Continue reading Where Are Clinical Trials Headed in 2022?
Clinical Trials As Potential Treatment How Chronic Illness and Elective Surgery Patients Might Turn to Clinical Trials During COVID Delays COVID-19 has caused the medical industry its biggest upheavals in living memory, and the current spikes of the Omicron variant are exacerbating those disruptions even further. Even with a lower reliance on ICU beds and… Continue reading Clinical Trials As Potential Treatment
US:
867 Boylston Street
5th Floor
Boston, MA 02116
